Natural Killer Dendritic Cells in Listeria Infection
李斯特菌感染中的自然杀伤树突状细胞
基本信息
- 批准号:7232468
- 负责人:
- 金额:$ 22.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-06-01 至 2009-05-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAntigensBioterrorismBrefeldin ACellsConditionCountCytolysisDataDendritic CellsEnvironmentExposure toHumanITGAX geneImmune responseImmunityImmunologicsIn VitroInfectionInflammatory ResponseInterferon Type IIInterferonsInterleukin-12Interleukin-18LabelListeriaListeria monocytogenesListeriosisLiverLyticMeasuresMessenger RNAMusNatural Killer CellsOrganPhysiologicalPolymerase Chain ReactionPopulationProductionProteinsResearch PersonnelRodentRoleSourceSpleenSplenocyteT-LymphocyteTLR9 geneTechniquesTestingThymus GlandTimeWild Type Mouseautocrinebasecell typecytokinehuman mortalityin vivointerferon alfacon-1lymph nodesnovelpathogenresearch studyresponse
项目摘要
DESCRIPTION (provided by applicant): While there is general consensus that interferon-gamma (IFN-gamma) is vital to the clearance of Listeria monocytogenes, the cellular source of IFN-gamma has been controversial. Some investigators have concluded that NK cells are responsible, while others have implicated T cells. Recently, we have identified a novel cell type that secretes large amounts of IFN-gamma and exists in the spleen and other organs of normal mice. Because these unique cells lyse targets directly, activate naive T cells in vitro and in vivo, and express both the natural killer cell marker NK1.1 and the dendritic cell marker CD11c, we have labeled them as natural killer dendritic cells (NKDC). A few other investigators have recognized NKDC-like cells in rodents and humans. We have preliminary data that splenic NKDC produce IFN-gamma during Listeria infection in mice. Therefore, we hypothesize that NKDC are critical to the immune response against Listeria. While the lytic and antigen-presenting abilities of NKDC may be important, we have chosen to focus exclusively on their IFN-gamma production for this 2-year application. We propose to assess the biologic significance of IFN-gamma production by NKDC during Listeria infection in mice and dissect the mechanisms by which it is regulated. In Aim 1, we will determine the extent of NKDC involvement in IFN-gamma production during Listeria infection. To exclude the possibility that other cells make IFN-gamma in vivo, but are unable to do so once they are removed from their local environment in the spleen, we will make use of a recently described technique of in vivo intracellular cytokine analysis of splenocytes. In Aim 2, we will establish the mechanism of IFN-gamma production by NKDC during Listeria infection. Specifically, we will test IL-12, IL-18, and Toll-like receptor 9 as we have found these to regulate NKDC IFN-gamma production in response to bacterial CpG. In Aim 3, we will determine whether NKDC production of IFN-gamma is sufficient to induce an immune response against Listeria. We will adoptively transfer NKDC from wild-type mice into IFN-gamma deficient mice and then assess their response to Listeria infection. NKDC will be compared to NK cells and other splenic cell subsets that make IFN-gamma as identified in Aim 1. Our proposed experiments will begin to define the role of NKDC in the immune response to Listeria, a pathogen that is a cause of human mortality and a potential agent for bioterrorism, and provide a greater understanding of how this novel cell type may participate in other types of immunity.
描述(由申请人提供):虽然人们普遍认为干扰素- γ (ifn - γ)对单核增生李斯特菌的清除至关重要,但ifn - γ的细胞来源一直存在争议。一些研究人员得出结论,NK细胞是罪魁祸首,而另一些人则认为是T细胞。最近,我们在正常小鼠的脾脏和其他器官中发现了一种分泌大量ifn - γ的新细胞类型。由于这些独特的细胞直接裂解靶标,在体外和体内激活幼稚T细胞,并表达自然杀伤细胞标记物NK1.1和树突状细胞标记物CD11c,我们将它们标记为自然杀伤树突状细胞(NKDC)。其他一些研究人员已经在啮齿动物和人类身上发现了类似nkdc的细胞。我们有初步的数据,脾NKDC产生干扰素γ在李斯特菌感染小鼠。因此,我们假设NKDC对李斯特菌的免疫反应至关重要。虽然NKDC的裂解和抗原呈递能力可能很重要,但我们选择在这个为期2年的应用中只关注其ifn - γ的产生。我们建议评估小鼠李斯特菌感染期间NKDC产生ifn - γ的生物学意义,并剖析其被调节的机制。在目的1中,我们将确定NKDC在李斯特菌感染期间参与ifn - γ产生的程度。为了排除其他细胞在体内产生ifn - γ,但一旦它们从脾脏的局部环境中移除就无法产生ifn - γ的可能性,我们将利用最近描述的脾细胞体内细胞内细胞因子分析技术。在Aim 2中,我们将建立NKDC在李斯特菌感染期间产生ifn - γ的机制。具体来说,我们将测试IL-12、IL-18和toll样受体9,因为我们已经发现这些受体在细菌CpG的作用下调节NKDC ifn - γ的产生。在Aim 3中,我们将确定NKDC产生的ifn - γ是否足以诱导对李斯特菌的免疫反应。我们将通过将野生型小鼠的NKDC转移到ifn - γ缺陷小鼠中,然后评估它们对李斯特菌感染的反应。NKDC将与NK细胞和其他在Aim 1中鉴定的产生ifn - γ的脾细胞亚群进行比较。我们提出的实验将开始确定NKDC在李斯特菌免疫反应中的作用,李斯特菌是一种导致人类死亡的病原体,也是生物恐怖主义的潜在病原体,并为这种新型细胞类型如何参与其他类型的免疫提供更好的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ronald P Dematteo其他文献
Ronald P Dematteo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ronald P Dematteo', 18)}}的其他基金
SURGICAL ONCOLOGY RESEARCH TRAINING PROGRAM AT PENN
宾夕法尼亚大学肿瘤外科研究培训项目
- 批准号:
10445265 - 财政年份:2020
- 资助金额:
$ 22.16万 - 项目类别:
SURGICAL ONCOLOGY RESEARCH TRAINING PROGRAM AT PENN
宾夕法尼亚大学肿瘤外科研究培训项目
- 批准号:
10023771 - 财政年份:2020
- 资助金额:
$ 22.16万 - 项目类别:
SURGICAL ONCOLOGY RESEARCH TRAINING PROGRAM AT PENN
宾夕法尼亚大学肿瘤外科研究培训项目
- 批准号:
10202527 - 财政年份:2020
- 资助金额:
$ 22.16万 - 项目类别:
SURGICAL ONCOLOGY RESEARCH TRAINING PROGRAM AT PENN
宾夕法尼亚大学肿瘤外科研究培训项目
- 批准号:
10646464 - 财政年份:2020
- 资助金额:
$ 22.16万 - 项目类别:
Molecular Mechanisms in Gastrointestinal Stromal Tumor
胃肠道间质瘤的分子机制
- 批准号:
9753726 - 财政年份:2017
- 资助金额:
$ 22.16万 - 项目类别:
Molecular Mechanisms in Gastrointestinal Stromal Tumor
胃肠道间质瘤的分子机制
- 批准号:
9547053 - 财政年份:2017
- 资助金额:
$ 22.16万 - 项目类别:
Natural Killer Dendritic Cells in Listeria Infection
李斯特菌感染中的自然杀伤树突状细胞
- 批准号:
7131216 - 财政年份:2006
- 资助金额:
$ 22.16万 - 项目类别:
Molecular Mechanisms in Gastrointestinal Stromal Tumor
胃肠道间质瘤的分子机制
- 批准号:
7367879 - 财政年份:2004
- 资助金额:
$ 22.16万 - 项目类别:
Molecular Mechanisms in Gastrointestinal Stromal Tumor
胃肠道间质瘤的分子机制
- 批准号:
9977132 - 财政年份:2004
- 资助金额:
$ 22.16万 - 项目类别:
Liver Dendritic Cells in Tolerance and Immunity
肝树突状细胞的耐受性和免疫
- 批准号:
6815631 - 财政年份:2004
- 资助金额:
$ 22.16万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:
BB/Y006224/1 - 财政年份:2024
- 资助金额:
$ 22.16万 - 项目类别:
Research Grant
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
- 批准号:
10083718 - 财政年份:2023
- 资助金额:
$ 22.16万 - 项目类别:
Small Business Research Initiative
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
- 批准号:
480030 - 财政年份:2023
- 资助金额:
$ 22.16万 - 项目类别:
Operating Grants
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
- 批准号:
MR/X009254/1 - 财政年份:2023
- 资助金额:
$ 22.16万 - 项目类别:
Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
- 批准号:
22KJ1758 - 财政年份:2023
- 资助金额:
$ 22.16万 - 项目类别:
Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
- 批准号:
BB/Y000927/1 - 财政年份:2023
- 资助金额:
$ 22.16万 - 项目类别:
Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
- 批准号:
10795212 - 财政年份:2023
- 资助金额:
$ 22.16万 - 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
- 批准号:
23K18249 - 财政年份:2023
- 资助金额:
$ 22.16万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
- 批准号:
10735075 - 财政年份:2023
- 资助金额:
$ 22.16万 - 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
- 批准号:
10645989 - 财政年份:2023
- 资助金额:
$ 22.16万 - 项目类别:














{{item.name}}会员




